gate complementary to the initiation region of vesicular stomatitis virus (VSV) N-protein mRNA specifically inhibits the synthesis of VSV proteins and exerts an antiviral activity against VSV when added in the cell culture medium at doses as low as 100 nM. Neither synthesis of cellular proteins nor multiplication of encephalomyocarditis virus was affected significantly by this oligonucleotide conjugate. The data suggest that oligonucleotide-poly(L-lysine) conjugates might become effective for studies on gene expression regulation and for antiviral chemotherapy.
Naturally occurring RNA sequences that negatively control the expression of certain genes have been discovered recently in prokaryotes (1) . Their inhibitory action on gene expression probably arises from specific hybridization of short transcripts to complementary sequences in mRNAs (2, 3) . No such sequences have yet been documented in eukaryotes.
Several lines ofevidence suggest that selective inhibition of gene expression can be achieved artificially through the introduction and expression of oligonucleotidic interfering sequences in intact cells. RNA and DNA oligonucleotide sequences effectively block translation in cell-free experiments (4) (5) (6) . An early study reported the antiviral activity of a 13-mer oligodeoxyribonucleotide in intact Rous sarcoma virus-infected fibroblasts (7) . Works by Inouye and his colleagues (8, 9) on prokaryotes and by Izant and Weintraub (3, 10) on eukaryotes demonstrated that exogenous antisense sequences could be used for specific regulation of gene expression in intact cells. Antisense RNAs were generated by transcription of sequences inserted in reverse orientation downstream from various promoters on recombinant plasmids introduced into intact cells by standard transfection techniques. These initial observations were followed by a flurry of works (see refs. 1 and 11 for reviews) aimed at probing the possibility of regulating gene expression through antisense RNAs in various biological systems, at deriving tools to achieve their efficient introduction and expression in cultured cells or in multicellular organisms, and at studying mechanism(s) involved in such controls. This technology indeed provides an alternative to standard mutational analysis, which is often difficult and sometimes impossible to achieve in diploid cells or organisms. Alternatively, it might become a pharmacological tool for the negative regulation of expression of deleterious cellular (e.g., deregulated oncogenes) or foreign (e.g., viral) genes.
As briefly mentioned above, antisense sequences were transiently expressed from recombinant plasmids introduced in intact cells by standard transfection studies (e.g., see refs. 8 and 10) or by microinjection (e.g., see refs. 3, 12, and 13). In a few cases, cells were engineered to express their own antisense RNA from stably integrated chromosomal genes (14) (15) (16) . Using a rather different approach, Miller, Ts'o, and their colleagues synthesized nonionic methylphosphonate oligodeoxyribonucleotide analogues, which possess increased resistance to nucleolytic degradation and penetrate the plasma membrane of mammalian cells growing in culture while retaining their ability to hybridize specifically to complementary RNA or DNA sequences (see refs. 17 and 18 for reviews). Short methylphosphonate oligodeoxyribonucleotides (8 or 9 nucleotides long) complementary to the initiation codon region of NS protein of vesicular stomatitis virus (VSV) (18) or to the acceptor splice junction of an immediateearly herpes simplex virus type 1 (HSV-1) pre-mRNA (19) reduced virus titers by --1 logarithmic unit when infected cells were treated with 150 tiM and 75 gM oligomers, respectively. Similarly, C. Helene and co-workers used acridine-conjugated oligodeoxyribonucleotides to regulate the expression of several viral genes in cell-free extracts (6, 20) and in intact cells (C. Helene, personal communication).
We have derived an alternative method for the delivery of antisense sequences to intact cells. It consists of chemical conjugation of oligodeoxyribonucleotides to poly(L-lysine) E-amino groups through a N-morpholine ring (21 (3.4 g/liter), penicillin (60 units/ml), and streptomycin (50 mg/ml). The Indiana strain of VSV or encephalomyocarditis virus (EMCV) was grown in L929 cell monolayers and titrated by an end-point method (22) .
Synthesis of Oligonucleotides. Oligodeoxyribonucleotides were synthesized using a Biosearch Sam One DNA synthesizer using the phosphotriester method. Deprotected oligonucleotides were purified on a Sephadex G-50 column equilibrated with 10 mM triethylamine bicarbonate buffer (pH 7.5) (TEAB). TEAB was eliminated by evaporation and the purity of this fraction was assayed by PAGE (23) . If necessary, the oligonucleotides were further purified by preparative PAGE in conditions similar to those of analysis.
Addition of pCp to Oligodeoxyribonucleotides. We adapted conditions from published reports (24, 25 We measured radioactivity and A260 of each fraction. Fractions containing the oligodeoxyribonucleotide pCp were pooled and evaporated to dryness.
Conjugation of Oligodeoxyribonucleotide pCp to POIY(LLysine). Dried oligodeoxyribonucleotide pCp was solubilized in 50 ,ul of 10 mM TEAB and incubated for 1 hr at 37°C with 1 unit of bacterial alkaline phosphatase. The dephosphorylated oligodeoxyribonucleotide was purified on Biogel P6-DG in 10 mM TEAB and lyophilized. The residue was solubilized in 100 ,ul of sodium metaperiodate (1 ,umol in 0.1 M sodium acetate buffer, pH 4.75), and the reaction mixture was incubated for 2 hr at 0°C-4°C in the dark. Poly(L-lysine) (100 ,ul) (80 nmol in 0.2 M phosphate buffer, pH 8.0) and 100 ,ul of sodium cyanoborohydride (10 ,mol in 0.2 M phosphate buffer, pH 8.0) were then added and incubation was allowed to proceed for 2 hr at room temperature. The sample was then loaded on a Sephadex G-50 column equilibrated and eluted with 0.1 M ammonium acetate buffer (pH 4.5). Each fraction was assayed for oligodeoxyribonucleotide-poly(L-lysine) content using Lowry's method (26) , by absorbance at 260 nm, and by measurement of radioactivity.
Protein Synthesis Assay. L929 cell cultures (3-5 x 105 cells) were washed twice with methionine-free minimal essential medium (MEM) and labeled for 45 min at 37°C with 185 kBq of [35S]methionine in 500 ,u1 of methionine-free MEM. Proteins were extracted and analyzed by gradient NaDodSO4/ PAGE (7.5-15%, wt/vol) as described (21) . Protein distribution in the gels was analyzed by fluorography (27) and quantitated with a Vernon densitometer on the autoradiographs. Oxidation of the 3'-terminal cytidylic residue and its coupling to E-amino groups of poly(L-lysine) were then performed as described for the conjugation of (2'-5')(A), to poly(L-lysine) (21) . An outline of the overall procedure used for the conjugation of oligodeoxyribonucleotides to poly(Llysine) is given in Fig. 1 . The length of the oligodeoxyribonucleotide was defined by taking into account published reports (1, 13, 18) and our previous experience in handling (2'-5')(A)n-poly(L-lysine) conjugates. Two to five (2'-5')(A) tetramers could be coupled to one molecule of poly(L-lysine) of 66 amino acid residues (Mr, 14,000) without any precipitation of the conjugate and delivered in a functional form within intact cells. On the other hand, a minimal length was necessary to hybridize with the target mRNA, and longer oligonucleotidic sequences have a higher probability of specific hybridization. The molecular weight of the poly(Llysine) carrier also seems of importance for efficiency (data not shown). The best results were obtained by coupling oligomers ranging in size from 10 to 15 nucleotides to Mr 14,000 poly(L-lysine).
RESULTS

Conjugation of Oligodeoxyribonucleotides and Poly(L-Lysine
The reasoning for identification of a possible target for antisense oligodeoxyribonucleotide in this system was as follows. The VSV genome consists of a single RNA negative strand of -11,000 nucleotides, encoding five proteins: N, NS, M, G, and L (30, 31) . The N protein coats the entire length of the virion RNA and plays roles in the replication of the genome and possibly in transcription (32) . In most studies so far, the best inhibitory effect of synthetic anti-mRNA oligonucleotides was obtained with oligomers complementary to the 5' region of the target mRNA, including or not the AUG initiation codon (e.g., see refs. 9, 10, and 18).
Two oligodeoxyribonucleotides were thus synthesized. The first (oligodeoxyribonucleotide 1 in Fig. 2 ) was 15 nucleotides long and complementary to the 5' end region of the mRNA coding for the N protein of VSV. It may hybridize with the major ribosome protected initiation site around the 5' proximal AUG codon. The second (oligodeoxyribonucleotide 2 in Fig. 2 ) was an internal sequence of 13 nucleotides located in the middle of the coding region of this 1326-nucleotide mRNA (33) . These synthetic oligomers were covalently linked to poly(L-lysine) as described above with an average molar ratio of 0.5 and a 25-30% yield. (22) . Preliminary experiments indicate that the conjugate is still efficient when added shortly (e.g., 2 hr) after VSV infection (data not shown).
As reported in Table 1 for three independent experiments, a dose-dependent reduction of VSV yield was observed in every case. The antiviral activity was detectable with conjugate concentration in the culture medium as low as 100 nM and reached >95% inhibition at 400 nM. Furthermore, and whatever the concentration of the conjugate, no significant effect on EMCV production was observed, unlike antiviral activity on VSV. This demonstrated the specificity of the antiviral action of the 5' end sequence conjugated to poly(Llysine).
In addition, no significant antiviral activity was observed when L929 cells were incubated with a mixture of poly(Llysine) and 5' end sequence oligomers. In agreement with our previous data on (2'-5')(A),, oligonucleotides (21), this result demonstrates that a covalent linkage of the oligodeoxyribonucleotide to poly(L-lysine) is necessary to obtain a biological activity. Moreover, no effect on virus multiplication was observed when cells were incubated with poly(L-lysine) ( Fig. 3 ). As illustrated in Fig. 4 , this ratio decreases from 25 to 0.1 for N protein and from 13 to a nonmeasurable level for M protein in parallel with the increase of the oligodeoxyribonucleotide concentration.
As illustrated in Fig. 5 , total acid-precipitable radioactivity remained unchanged when uninfected cells were incubated with increasing concentrations of the 5' end sequence conjugate. A dose-dependent increase in protein synthesis was observed when cells were treated with increasing concentrations of the same 5' end sequence conjugate, challenged with VSV (moi = 1) 2 hr later and pulse-labeled with [35S]methionine 6 hr after infection. Once again, a mixture of unconjugated 200-pmol oligodeoxyribonucleotide and 400-pmol poly(L-lysine) did not alter total protein synthesis in VSVinfected cells.
This last set of results confirms the antiviral activity of the conjugate, the necessity of coupling to observe such activity, the specificity of our product, and the absence of toxicity in the doses used on L929 cells. gates. This and the absence of effect of a mixture of the oligonucleotide sequence and poly(L-lysine) conclusively eliminate a possible trivial effect of oligonucleotide-poly(Llysine) conjugates on the initial steps of VSV-cell interaction or on some cellular components indispensable for viral development.
The fact that an oligonucleotide complementary to VSV N protein mRNA and to none of the other VSV mRNAs inhibits to the same extent the synthesis of VSV M protein (and probably also of the other viral proteins) has been found by others (18) and does not arise from the lack of specificity. As for many viruses, efficient VSV multiplication requires an initial amplification of its genomic RNA; in addition, viral RNA must be coated with the nucleocapsid N protein to function as a template (35) . A reduction in the translation of Biochemistry: Lemailtre et al. N protein mRNA should therefore react on the accumulation of all five VSV proteins, as was observed. Alternatively, an oligonucleotide sequence complementary to one of the VSV mRNAs could also be hybridized, at least in principle, with the 40S plus-strand RNA serving as a template for the replication of virion RNA (36) . This probably does not contribute to a large extent to the antiviral action and to the viral protein synthesis inhibitory activity of our conjugate since one would then have expected the oligonucleotide sequence complementary to an internal site of VSV N-protein mRNA to be as efficient as that of translation initiation.
Apart from its specificity, the inhibition of viral protein synthesis attained with oligodeoxyribonicleotide-poly(L-lysine) conjugates is remarkable for its efficiency as compared with data published so far in this field. The efficient inhibition of gene expression by antisense sequences in cell-free extracts or in intact cells usually requires concentrations of oligonucleotide sequences in the 50-500 ,uM range, although differences in the biological models investigated render comparisons difficult. Neutral methylphosphonate oligonucleotide derivatives (18) for instance have to be added at :100 times higher concentrations in the culture medium to reduce VSV multiplication in mouse L cells to a comparable extent as with poly(L-lysine) conjugates. This seemingly higher efficiency of poly(L-lysine) oligonucleotide conjugates could obviously result from several factors such as increased uptake and delivery to the appropriate cell compartment, better functional stability, or higher affinity for the target nucleotidic sequence. Too little is known at present about their metabolism, the pathway of their internalization, and their site of action in the cell to reach a conclusion, but several of these points are worth investigating further.
In summary, conjugation of properly located oligodeoxynucleotide sequence to poly(L-lysine) promotes a specific and efficient antiviral activity when the conjugates are incubated with cultured cells. This convenient and versatile tool should in principle make it possible to interfere specifically with the expression of any viral or cellular gene in vitro and possibly also in vivo. Moreover, the methodology used here to link an oligonucleotide sequence to E-amino residues of lysine in poly(L-lysine) could conceivably be used for coupling them to amino groups in other synthetic or natural polypeptides, thus allowing targeting of the conjugated sequence to cells or tissues bearing specific cell-surface determinants.
